Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function
Heikki Laurikainen(University of Turku), Jaana Suvisaari, Anna Toivonen(University of Turku), Jaakko Keinänen(Finnish Institute for Health and Welfare), Outi Vaarala(Orion Corporation (United Kingdom)), Tuula Kieseppä(Hospital District of Helsinki and Uusimaa), Kalevi Trontti(University of Helsinki), Janina Paju(University of Turku), Jarno Honkanen(University of Helsinki), Teemu Mäntylä(University of Helsinki), Sebastian Therman(Finnish Institute for Health and Welfare), Päivi Marjamäki(University of Turku), Tuula Ilonen(University of Turku), Jouni Tuisku(University of Turku), Iiris Hovatta(University of Helsinki), Arja Vuorela(University of Helsinki), Raimo K. R. Salokangas(University of Turku), Reetta-Liina Armio(University of Turku), Jarmo Hietala(University of Turku), Maija Walta(University of Turku), Semi Helin(Nature Conservation Centre), Maija Lindgren(Finnish Institute for Health and Welfare), Linnea Reinert‐Hartwall(University of Helsinki)
Cited by 26
Related Papers
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
|The American Journal of Human Genetics|2003|1.1k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773